Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
56.50
+3.30 (6.20%)
At close: Jul 22, 2026
-7.21% (1Y)
| Market Cap | 3.77B -6.3% |
| Revenue (ttm) | 373.49M +26.6% |
| Net Income | 109.68M +24.5% |
| EPS | 1.64 +23.4% |
| Shares Out | 66.70M |
| PE Ratio | 34.44 |
| Forward PE | n/a |
| Dividend | 0.70 (1.32%) |
| Ex-Dividend Date | Jun 1, 2026 |
| Volume | 2,313,577 |
| Open | 53.00 |
| Previous Close | 53.20 |
| Day's Range | 52.67 - 56.64 |
| 52-Week Range | 44.88 - 92.50 |
| Beta | 0.03 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 21, 2026 |